Sponsor or institution
Clinical trials and research at Leipzig Heart Science gGmbH
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Leipzig Heart Science gGmbH that are recruiting, at sites in 2 countries (most in Germany (6), Austria (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Left Ventricular Support and Advanced Monitoring in AMI–Cardiogenic Shock: Immediate Impella Use and PAC/Monitoring vs Standard Care | — | Leipzig, Saxony | Recruiting | Aug 13, 2026 |
| CRP Apheresis for infarct-related cardiogenic shock | — | Leipzig, Saxony | Recruiting | Jul 7, 2026 |
| Early treatment for high-risk pulmonary embolism using catheters | — | Bad Krozingen and 17 other locations | Recruiting | Nov 4, 2024 |
| Comparing complete revascularization to culprit lesion only PCI in NSTEMI patients | — | Graz and 57 other locations | Recruiting | Mar 27, 2023 |
| Registry of cardiac arrests in children with congenital heart disease | — | Leipzig, Saxony and 2 other locations | Recruiting | May 13, 2022 |
| Registry for out-of-hospital cardiac arrest cases in Germany | — | Berlin, State of Berlin and 24 other locations | Recruiting | Dec 2, 2021 |
All recruiting trials (6)
-
Left Ventricular Support and Advanced Monitoring in AMI–Cardiogenic Shock: Immediate Impella Use and PAC/Monitoring vs Standard Care
In adults with heart attack-related cardiogenic shock, this trial tests whether using an Impella left ventricular assist device and/or protocolized pulmonary artery catheter monitoring improves survival compared with standard care.
-
CRP Apheresis for infarct-related cardiogenic shock
This study tests whether selectively removing C-reactive protein with apheresis, in addition to standard care, helps people with cardiogenic shock after a heart attack.
-
Early treatment for high-risk pulmonary embolism using catheters
This study tests if using a special catheter treatment right away, along with standard care, can help people with severe pulmonary embolism recover better and survive longer.
-
Comparing complete revascularization to culprit lesion only PCI in NSTEMI patients
This study tests if treating all blocked arteries instead of just the main problem artery helps people with NSTEMI feel better and recover faster.
-
Registry of cardiac arrests in children with congenital heart disease
This study is collecting information on cardiac arrests in children with congenital heart disease in Germany to see how these events affect their recovery and overall health.
-
Registry for out-of-hospital cardiac arrest cases in Germany
This study is collecting information on people who have heart attacks outside of the hospital in Germany to see how they are treated and how to improve their care.
Quick answers
How many clinical trials run by Leipzig Heart Science gGmbH are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (6 trials), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.